Skip to content
beroni logo newberoni logo new
  • About
    • About Beroni
    • Our History
    • Board of Directors
    • Management Team
    • Vision, Mission and Values
  • R&D
    • R&D
    • PENAO
      • PENAO Introduction
      • About
      • Board & Senior Management
      • Asset Protection
      • Research & Development​
      • Value Proposition
  • Core Businesses
    • Cell Therapies
    • Anti-Cancer Drugs
    • Infectious Diseases
    • Infectious Diseases – COVID-19
    • E-commerce
  • Products
    • By Beroni GuangDong
    • By Beroni Tianjin
    • By Beroni USA
    • By Beroni Biotech
  • Investors
    • Announcements
    • Financial Information
    • Corporate Governance
    • Stock Information
    • Globenewswire Press Releases
    • Medtech Outlook
    • Research Report
    • COVID-19 Vaccines Overview
    • FAQs
  • News
  • Contact
  • English
    • 简体中文
Menu Close

Daily Archives: 2021-10-22

  1. Home>
  2. 2021>
  3. October>
  4. 22
Read more about the article Successful Conclusion to Beroni Group’s 2021 Team Building Activity
All members is ready to go Pinggu district, Beijing

Successful Conclusion to Beroni Group’s 2021 Team Building Activity

  • Post author:tnt
  • Post published:2021-10-22
  • Post category:2021
  • Post comments:0 Comments

In order to enhance the cohesiveness and centripetal force of Beroni team and enrich the cultural life of employees, Beroni Group organized a team building activity with the theme of…

Continue ReadingSuccessful Conclusion to Beroni Group’s 2021 Team Building Activity

Search Article

Arrange by Year

  • 2017 (10)
  • 2018 (24)
  • 2019 (25)
  • 2020 (17)
  • 2021 (11)
  • 2022 (8)
  • 2023 (6)
  • 2024 (8)
  • 2025 (1)

What’s New

  • Beroni Pharmaceuticals Nucleic Acid Drug CRO Services
  • Beroni Group’s AI-based Drug R&D Model Achieves Technological Breakthrough
  • Beroni Group Has Made Significant Progress in the Field of iNKT Cell Anti-tumor Therapy
  • Beroni Group Has Successfully Developed a New Method for Improving Safety of Neural Stem Cells Used in the Treatment of Neurodegenerative Diseases
  • Beroni Group’s Ten-year Research Journey, Innovation Leads the Future

Beroni Group is an international biotechnological company listed on the National Stock Exchange (Australia) and traded on the OTC markets in the USA with business presence in Australia, China, Japan and the USA. It currently has four core businesses – research and development of new drugs and clinical trial, immune cell therapy including gene detection and diagnosis, immunotherapy for cancer treatment, diagnosis of infectious diseases and e-commerce based on the Internet sales of pharmaceutical, healthcare and cosmetic products.

About

  • About Beroni
  • Our History
  • Board of Directors
  • Management Team
  • Vision, Mission, and Values

Core Businesses

  • Cell Therapy
  • Anti-Cancer Drugs
  • Infectious Diseases
  • E-Commerce

Products

  • By Beroni China
  • By Beroni Japan
  • By Beroni USA

Copyrights© Beroni Group 2019 | All rights reserved |

website by chase e-Design

Close Menu